Cargando…

Interleukin-21 activates natural killer cell activity against cetuximab-coated pancreatic tumor cells

Detalles Bibliográficos
Autores principales:	McMichael, Elizabeth L, Jaime-Ramirez, Alena Cristin, Guenterberg, Kristan, Luedke, Eric, Atwal, Lakhvir, Carson, William E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649352/ http://dx.doi.org/10.1186/2051-1426-3-S2-P233

Ejemplares similares

Are Peripheral Natural Killer Cells and Interleukin-21 Interrelated in Psoriasis Pathogenesis?
por: Hegab, Doaa Salah, et al.
Publicado: (2017)

Enhanced natural killer cell targeting of cancer stem cells using Cetuximab
por: Grossenbacher, Steven K, et al.
Publicado: (2014)

Cetuximab-induced natural killer cell cytotoxicity in head and neck squamous cell carcinoma cell lines: investigation of the role of cetuximab sensitivity and HPV status
por: Baysal, Hasan, et al.
Publicado: (2020)

Interleukin 5 enhances interleukin 2-mediated lymphokine-activated killer activity
Publicado: (1989)

Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer
por: Fasano, Morena, et al.
Publicado: (2020)

Activation of natural killer cells via the p75 interleukin 2 receptor
Publicado: (1989)

Lymphokine-activated killer cell phenomenon. Lysis of natural killer- resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes
Publicado: (1982)

Inhibition by Fibrin Coagulation of Lung Cancer Cell Destruction by Human Interleukin‐2‐activated Killer Cells
por: Atagi, Shinji, et al.
Publicado: (1992)

Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen
Publicado: (1988)

Gene expression profiling of the human natural killer cell response to Fc receptor activation: unique enhancement in the presence of interleukin-12
por: Campbell, Amanda R., et al.
Publicado: (2015)

Combination Treatment with Irritant and Recombinant Interleukin 2 in the Peritoneal Cavity for Evoking Effective Anti‐tumor Activity: Generation of Lymphokine‐activated Killer Cells and Tumor‐specific Killer Cells
por: Uchida, Hiroyuki, et al.
Publicado: (1990)

Synergy of Nocardia rubra Cell Wall Skeleton and Interleukin 2 in the in vivo Induction of Murine Lymphokine‐activated Killer Cell Activity
por: Kawase, Ichiro, et al.
Publicado: (1989)

Monocyte expression of MICA enhances the Natural Killer Cell response to antibody-coated tumor targets
por: Harper, Amanda, et al.
Publicado: (2014)

Syndecan-1-coating of interleukin-17-producing natural killer T cells provides a specific method for their visualization and analysis
por: Jaiswal, Anil Kumar, et al.
Publicado: (2017)

Human Alveolar Macrophages Augment Natural Killer Cell Stimulatory Factor (Interleukin‐12)‐inducible Killer Activity from Autologous Blood Lymphocytes
por: Haku, Takashi, et al.
Publicado: (1995)

Tumour necrosis factor-alpha enhances the cytolytic and cytostatic capacity of interleukin-2 activated killer cells.
por: Matossian-Rogers, A., et al.
Publicado: (1989)

Efficacy of chemoimmunotherapy with cyclophosphamide, interleukin-2 and lymphokine activated killer cells in an intraperitoneal murine tumour model.
por: Eggermont, A. M., et al.
Publicado: (1988)

The effects of recombinant interleukin 2-activated natural killer cells on autologous peripheral blood hematopoietic progenitors
Publicado: (1988)

Inhibition of natural killer (nk) cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome
por: Cifaldi, Loredana, et al.
Publicado: (2014)

Natural Killer Cell Activity and Interleukin-12 in Metabolically Healthy versus Metabolically Unhealthy Overweight Individuals
por: Kim, Minjoo, et al.
Publicado: (2017)

Activating and inhibitory receptors on natural killer cells in patients with systemic lupus erythematosis-regulation with interleukin-15
por: Lin, Syh-Jae, et al.
Publicado: (2017)

The effect of interleukin-15 on the expression of killer-cell immunoglobulin-like receptors on peripheral natural killer cells in human.
por: Kogure, Toshiaki, et al.
Publicado: (2002)

Do phenothiazines contribute to tumour regressions in lymphokine-activated killer cell/interleukin-2 treatments of renal cell cancer?
por: Sauter, C.
Publicado: (1987)

Elotuzumab enhances natural killer cell activation and myeloma cell killing through interleukin-2 and TNF-α pathways
por: Balasa, Balaji, et al.
Publicado: (2014)

Induction by Interleukin‐15 of Human Killer Cell Activity against Lung Cancer Cell Lines and Its Regulatory Mechanisms
por: Takeuchi, Eiji, et al.
Publicado: (1996)

Effect of interleukins (IL-2, IL-15, IL-18) on receptors activation and cytotoxic activity of natural killer cells in breast cancer cell
por: Widowati, Wahyu, et al.
Publicado: (2020)

Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma
por: Espinosa-Cotton, Madelyn, et al.
Publicado: (2019)

Corrigendum: Natural Killer Cell Activity and Interleukin-12 in Metabolically Healthy versus Metabolically Unhealthy Overweight Individuals
por: Kim, Minjoo, et al.
Publicado: (2018)

Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment
por: Galbiati, Donata, et al.
Publicado: (2019)

FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer
por: Marzi, L, et al.
Publicado: (2016)

Interleukin 4 (B cell stimulatory factor 1) can mediate the induction of lymphokine-activated killer cell activity directed against fresh tumor cells
Publicado: (1987)

Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential T/natural killer progenitor cells
Publicado: (1996)

Natural killer and lymphokine activated killer cell functions in Hodgkin's disease.
por: Rajaram, N., et al.
Publicado: (1990)

Expansion of natural killer cells but not T cells in human interleukin 2/interleukin 2 receptor (Tac) transgenic mice
Publicado: (1989)

Characterization of mouse natural killer cell activating factor (NKAF) induced by OK-432: evidence for interferon- and interleukin 2-independent NK cell activation.
por: Ichimura, O., et al.
Publicado: (1984)

Differential Activation of Lymphokine‐activated Killer Cells with Different Surface Phenotypes by Cultivation with Recombinant Interleukin 2 or T‐cell Growth Factor in Gastric Cancer Patients
por: Koyama, Shohei, et al.
Publicado: (1989)

Comparative analysis of interleukin 15 and interleukin 2 for induction of killer activity and of type 2 cytokine production by mononuclear cells from lung cancer patients.
por: Takeuchi, E., et al.
Publicado: (1998)

Interleukin‐33 as an early predictor of cetuximab treatment efficacy in patients with colorectal cancer
por: Zhang, Xujun, et al.
Publicado: (2021)

Interleukin 2-induced proliferation of murine natural killer cells in vivo
Publicado: (1990)

Effects of human interleukin-1 on natural killer cell activity: is fever a host defense mechanism for tumor killing?
por: Dinarello, C. A., et al.
Publicado: (1986)

Cannot write session to /tmp/vufind_sessions/sess_l0vfld2pbdph2aj7jeo5hmkv7k